{"nct_id":"NCT06991114","title":"AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.","status":"RECRUITING","status_verified_date":"2025-08","start_date":"2025-07-09","start_date_type":"ACTUAL","primary_completion_date":"2028-01","primary_completion_date_type":"ESTIMATED","completion_date":"2029-01","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["ARTV"]}